<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03601481</url>
  </required_header>
  <id_info>
    <org_study_id>API/2012/36</org_study_id>
    <nct_id>NCT03601481</nct_id>
  </id_info>
  <brief_title>Implementation and Validation of Telemedicine Software for the Automation of MRI Examinations of Acute Myocardial Infarctions</brief_title>
  <acronym>TELECARD</acronym>
  <official_title>Mise en Place et Validation d'un Logiciel de Télémédecine Permettant l'Automatisation du Traitement Des Examens IRM Des Infarctus du Myocarde en Phase Aigue</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Validation of a telemedicine software application for an automated treatment of&#xD;
      cardio-vascular MRI completely identical for both CHUs.&#xD;
&#xD;
      Providing the software application to other CHU seeking a tool suitable for multi-centric&#xD;
      studies.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Scientific context:&#xD;
&#xD;
           Cardiac MRI has become a standard technique for determining the size of myocardial&#xD;
           infarction as well as evaluating myocardial function and perfusion. However, the&#xD;
           quantitative analysis of the images targeted on the left and right ventricles relies on&#xD;
           computer treatments often manual so tedious and dependent on the user, or at best&#xD;
           semi-automatic. The absence of a completely automated method limits the extraction of&#xD;
           quantitative and reproducible parameters for each patient, which is necessary for the&#xD;
           follow-up of patients who have had an acute myocardial infarction.&#xD;
&#xD;
        2. Objective (s):&#xD;
&#xD;
           The goal is to integrate in a telemedicine software solution (partnership with the&#xD;
           company Covalia) an automated method of processing these data completely identical for&#xD;
           both CHUs. This development could be made available to other UHC seeking a tool suitable&#xD;
           for multicenter studies.&#xD;
&#xD;
        3. Materials and Methods:&#xD;
&#xD;
      An engineer will be recruited to develop algorithms for robust, reliable and ergonomic&#xD;
      software for the study of myocardial function and perfusion. The software will be accessible&#xD;
      by users via the internet, and will integrate all the security and personal protection&#xD;
      constraints that a telemedicine tool requires. The telemedicine aspect will be done in&#xD;
      partnership with the company Covalia, which obtained for its software solutions CE marking&#xD;
      thanks to an organization ISO 13485 applied to the whole of the company.&#xD;
&#xD;
      The images used for the realization of the software will be taken from the Besançon patient&#xD;
      examinations included in the previous PHRC (1) and will be used after anonymisation.&#xD;
&#xD;
      Validation of the software will be based on current BioCard PHRC examinations in Dijon and&#xD;
      Besançon. This study concerning the implementation and the validation of a software, a&#xD;
      hundred of cases will be included in order to obtain a sufficient representation of the&#xD;
      included population (ie sufficient observable variability) to validate the technical&#xD;
      characteristics of the software (reliability, reproducibility, sensitivity, precision).&#xD;
&#xD;
      The software will automatically provide the calculation of tele-diastolic and tele-systolic&#xD;
      volumes, ejection fraction, thickness and myocardial thickening. In addition, the study of&#xD;
      myocardial infusion after injection of a contrast medium will consist of the construction of&#xD;
      parametric perfusion maps, as well as an automatic determination of myocardial viability. The&#xD;
      development of the computer tool will be based on the software &quot;Quantified Imaging Resource&quot;,&#xD;
      developed by Alain Lalande and Alexandre Comte and whose results have already been the&#xD;
      subject of publications.&#xD;
&#xD;
      The aforementioned parameters will be calculated automatically (with the software) and&#xD;
      manually (2 experts will perform these calculations). The results will then be compared and&#xD;
      analyzed by the statisticians of the Besançon and Dijon clinical investigation centers&#xD;
&#xD;
      (1) : Détermination du taux et du type de progéniteurs vasculaires dans l'infarctus&#xD;
      myocardique avec et sans sus décalage du segment ST - 2005 - Dr Meneveau (cardiologie)&#xD;
&#xD;
      4- Expected results and perspectives (less than 30 words)&#xD;
&#xD;
        -  Complete software development and validation on the BioCard PHRC exams.&#xD;
&#xD;
        -  Integration of the software in a tele-medicine application.&#xD;
&#xD;
        -  Submission of at least two articles for international journals.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Software update needed&#xD;
  </why_stopped>
  <start_date type="Actual">March 3, 2014</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Actual">March 3, 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Precision of the localisation of endocardic and epicardic edge</measure>
    <time_frame>Day 2</time_frame>
    <description>Validation of a software telemedecine for automatic treatment of cardio-vascular MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume of myocardic cavity</measure>
    <time_frame>Day 2</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ejection fraction</measure>
    <time_frame>Day 2</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight of the myocard</measure>
    <time_frame>Day 2</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Thickness of the myocard</measure>
    <time_frame>Day 2</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Precision of the localisation of endocardic and epicardic edge</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume of myocardic cavity</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight of the myocard</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Thickness of the myocard</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">167</enrollment>
  <condition>Myocardial Infarction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Major patient with heart attack&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18 years and 75 yeras&#xD;
&#xD;
          -  heart attack with medical treatment within 12 hours&#xD;
&#xD;
          -  heart attack with or without segment S-T gap&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  cardiogenic choc&#xD;
&#xD;
          -  medical history with heart attack,&#xD;
&#xD;
          -  medical history with left ventricle dysfonction (ejection fraction&lt; 45%),&#xD;
&#xD;
          -  medical history with clinic manifestations of heart failure,&#xD;
&#xD;
          -  medical history with surgical coronary revascularisation in the last 6 months,&#xD;
&#xD;
          -  congenital cardiopathy, myocardiopathy,&#xD;
&#xD;
          -  evolutive infection syndrome (HIV, VHB, VHC),&#xD;
&#xD;
          -  chronic inflammatory pathology,&#xD;
&#xD;
          -  leucopenia, thrombopenia, anemia,&#xD;
&#xD;
          -  medical history with treatment by G-CSF; EPO; GM-CSF,&#xD;
&#xD;
          -  stasis trouble, evolutive hemorragic syndrome, transfusion,&#xD;
&#xD;
          -  renal insuffisance (clearance MDRD &lt; 60ml/min),&#xD;
&#xD;
          -  renal insuffisance with creatinin &gt; 120 µmol/L,&#xD;
&#xD;
          -  hepatic insuffisance,&#xD;
&#xD;
          -  medical history of cancer or pathology with life expectancy &lt; 1 year,&#xD;
&#xD;
          -  pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2017</verification_date>
  <study_first_submitted>July 17, 2018</study_first_submitted>
  <study_first_submitted_qc>July 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>July 26, 2018</last_update_submitted>
  <last_update_submitted_qc>July 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>telemedicine</keyword>
  <keyword>cardiac images</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

